COMMUNIQUÉS West-GlobeNewswire

L’événement Raise Craze de la Fondation du CUSM et de The Beat 92.5 recueille 95 000 $ pour aider à combattre le cancer du sein

01/11/2024 - 13:00

Tous les fonds appuient les soins du cancer du sein au Centre universitaire de santé McGill (CUSM) MONTRÉAL, 01 nov. 2024 (GLOBE NEWSWIRE) -- La Fondation du CUSM, en collaboration avec The Beat 92.5 et Pink in the City [...]

The MUHC Foundation and the Beat 92.5’s Raise Craze raises $95,000 to help strike out breast cancer

01/11/2024 - 13:00

All funds are supporting breast cancer care at the McGill University Health Centre (MUHC) MONTREAL, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The MUHC Foundation, in collaboration with The Beat 92.5 and Pink in the City, raised [...]

Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024

01/11/2024 - 13:00

BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]

TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update

01/11/2024 - 13:06

Conference call to be held Monday, November 4, 2024, at 8:30 AM ET NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday November 4 [...]

Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the ESSENCE trial

01/11/2024 - 13:13

Bagsværd, Denmark, 1 November 2024 – Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, double-blinded trial in 1,200 adults with metabolic [...]

Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial

01/11/2024 - 13:30

DENVER, Nov. 01, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on [...]

Galecto Reports Third Quarter 2024 Financial Results

01/11/2024 - 13:30

- Completed strategic review to focus on oncology and severe liver diseases - Announced acquisition of global rights to BRM-1420, a dual ENL-YEATS and FLT3 inhibitor for multiple genetic subsets of AML from Bridge [...]

Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control

01/11/2024 - 13:30

FemBloc issued patent provides additional coverage for Femasys’ therapeutic option for women seeking permanent birth control ATLANTA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical [...]

RTI Surgical Completes Acquisition of Collagen Solutions

01/11/2024 - 13:38

RTI Surgical Completes Acquisition of Collagen Solutions ALACHUA, Fla., November 1, 2024 – RTI Surgical ("RTI" or "the Company"), a leading CDMO pushing the boundaries of innovation and tissue engineering to meet [...]

Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024

01/11/2024 - 14:00

CARLSBAD, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it will implement a 1-for-50 reverse stock split of the issued shares of its common [...]

Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical

01/11/2024 - 14:15

SOUTH JORDAN, Utah, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today reported that it has completed the acquisition of Cook Medical’s lead [...]

Milestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty Care

01/11/2024 - 14:15

Recent Medicare Price Assignment Driving Increased Access to CompuFlo Milestone Scientific to Attend New York and New Jersey Pain Medicine Congress 2024 ROSELAND, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Milestone [...]

Safety Shot Expands Distribution to Chicagoland Grocery Stores

01/11/2024 - 14:45

The Company's rapid alcohol-reducing beverage, Sure Shot, launches in Pete's Fresh Market, Caputo's, Tony's Fresh Market, Festival Foods, and Sunset Foods. JUPITER, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Safety Shot, [...]

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

01/11/2024 - 15:34

HOUSTON, TX, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock Market (“Nasdaq”) on October 31 [...]

Legend Senior Living® Will Operate Newly Renamed Ridgecrest at Cranberry Woods Senior Living Residence

01/11/2024 - 16:21

WICHITA, Kan., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Legend Senior Living, with headquarters in Wichita, KS, has announced that it has assumed operations of Atria at Cranberry Woods and has renamed the residence Ridgecrest [...]

Zealand Pharma conference call on November 7 at 2pm CET (8am ET) to present third quarter 2024 financial results

01/11/2024 - 17:30

Press Release – No. 10 / 2024 Zealand Pharma conference call on November 7 at 2pm CET (8am ET) to present third quarter 2024 financial results Copenhagen, Denmark, November 1, 2024 – Zealand Pharma A/S (Nasdaq [...]

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data

01/11/2024 - 18:00

NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th

01/11/2024 - 19:00

HOUSTON, TX, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on November 5, 2024, at 4:15 p.m. ET. The exclusive [...]

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition

01/11/2024 - 20:05

IMPACT-TD Registry, the largest study evaluating holistic effects of tardive dyskinesia (TD), highlights that there is a high burden of TD on quality of life regardless of a person’s underlying mental health condition [...]